Metraipolis › archive › dc_f42aea12fedf

Advances in chimeric antigen receptor-natural killer cell therapy: from mechanisms and preclinical studies to clinical application — Europe PMC PMID:41635402

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41635402
DOI
10.3389/fonc.2025.1759796
License (as archived)
solo-consultazione
Archived
2026-11-06T17:00:17.360Z
SHA-256 of the archived text
c0a23bafaea64d3d67edf0d219a409acff2c2ab8dda64e14194b27ee465e1d5e
Stable URL of this page
https://metraipolis.com/documento/dc_f42aea12fedf

How to cite

Advances in chimeric antigen receptor-natural killer cell therapy: from mechanisms and preclinical studies to clinical application — Europe PMC PMID:41635402 — Europe PMC (en), https://europepmc.org/article/MED/41635402 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f42aea12fedf (Metraipolis archive dc_f42aea12fedf, sha256 c0a23bafaea64d3d67edf0d219a409acff2c2ab8dda64e14194b27ee465e1d5e)
BibTeX
@misc{dcf42aea12fedf,
  title = {Advances in chimeric antigen receptor-natural killer cell therapy: from mechanisms and preclinical studies to clinical application — Europe PMC PMID:41635402},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41635402},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f42aea12fedf; sha256 c0a23bafaea64d3d67edf0d219a409acff2c2ab8dda64e14194b27ee465e1d5e},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41635402. Agents can read the archived copy with the MCP tool read_document.